adplus-dvertising
Connect with us

Business

Canada begins review of Oxford coronavirus vaccine candidate – Global News

Published

 on


OTTAWA – Canada launched on Friday a real-time review of data from AstraZeneca and Oxford University’s potential COVID-19 vaccine, becoming the latest country to speed up its approval process.

Read more:
Canada signs deal to obtain 20M doses of Oxford coronavirus vaccine candidate

As the battle against the coronavirus pandemic intensifies, with infections and deaths still rising, Canada‘s health ministry said it had received its first submission for authorisation for the vaccine on Thursday.

The aim of a rolling review is to accelerate the process and last month, Canada‘s health minister Patty Hajdu signed an order allowing companies developing vaccines to submit safety and efficacy data and information as they become available.






1:40
Canada signs new coronavirus vaccine deals


Canada signs new coronavirus vaccine deals

Story continues below advertisement

The European Union’s health regulator on Thursday also started a rolling review of the first batch of data for the potential vaccine being worked on by AstraZeneca.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

The British drugmaker and Oxford University did not immediately respond to requests for comment.

Read more:
Should the COVID-19 vaccine be mandatory? New poll suggests Canadians are divided

The Canadian ministry will not decide whether to authorize this or any other vaccine until it has received the necessary evidence to support its safety, efficacy and quality, it said

It is also in talks with several vaccine manufacturers and said any company can apply to use the rolling review process.

Last week, Canada agreed to buy up to 20 million doses of the vaccine candidate, one of several deals it has signed to secure around 300 million potential shots as the global death toll from coronavirus exceeds 1 million.


Click to play video 'Coronavirus: AstraZeneca pauses COVID-19 vaccine trial after participant gets unexplained illness'



1:46
Coronavirus: AstraZeneca pauses COVID-19 vaccine trial after participant gets unexplained illness


Coronavirus: AstraZeneca pauses COVID-19 vaccine trial after participant gets unexplained illness

Called AZD1222 or ChAdOx1 nCoV-19, the AstraZeneca vaccine is seen as leading the race to inoculate people against COVID-19. Other vaccine hopefuls in advanced stages include those from Pfizer, Moderna and Sinovac.

Story continues below advertisement

— Reporting by Steve Scherer in Ottawa; additional reporting by Pushkala Aripaka in Bengaluru and Alistair Smout in London; Writing by Josephine Mason in London Editing by Chizu Nomiyama, Mark Potter and Alexander Smith

© 2020 Thomson Reuters

Let’s block ads! (Why?)

728x90x4

Source link

Business

TC Energy cuts cost estimate for Southeast Gateway pipeline project in Mexico

Published

 on

 

CALGARY – TC Energy Corp. has lowered the estimated cost of its Southeast Gateway pipeline project in Mexico.

It says it now expects the project to cost between US$3.9 billion and US$4.1 billion compared with its original estimate of US$4.5 billion.

The change came as the company reported a third-quarter profit attributable to common shareholders of C$1.46 billion or $1.40 per share compared with a loss of C$197 million or 19 cents per share in the same quarter last year.

Revenue for the quarter ended Sept. 30 totalled C$4.08 billion, up from C$3.94 billion in the third quarter of 2023.

TC Energy says its comparable earnings for its latest quarter amounted to C$1.03 per share compared with C$1.00 per share a year earlier.

The average analyst estimate had been for a profit of 95 cents per share, according to LSEG Data & Analytics.

This report by The Canadian Press was first published Nov. 7, 2024.

Companies in this story: (TSX:TRP)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

BCE reports Q3 loss on asset impairment charge, cuts revenue guidance

Published

 on

 

BCE Inc. reported a loss in its latest quarter as it recorded $2.11 billion in asset impairment charges, mainly related to Bell Media’s TV and radio properties.

The company says its net loss attributable to common shareholders amounted to $1.24 billion or $1.36 per share for the quarter ended Sept. 30 compared with a profit of $640 million or 70 cents per share a year earlier.

On an adjusted basis, BCE says it earned 75 cents per share in its latest quarter compared with an adjusted profit of 81 cents per share in the same quarter last year.

“Bell’s results for the third quarter demonstrate that we are disciplined in our pursuit of profitable growth in an intensely competitive environment,” BCE chief executive Mirko Bibic said in a statement.

“Our focus this quarter, and throughout 2024, has been to attract higher-margin subscribers and reduce costs to help offset short-term revenue impacts from sustained competitive pricing pressures, slow economic growth and a media advertising market that is in transition.”

Operating revenue for the quarter totalled $5.97 billion, down from $6.08 billion in its third quarter of 2023.

BCE also said it now expects its revenue for 2024 to fall about 1.5 per cent compared with earlier guidance for an increase of zero to four per cent.

The company says the change comes as it faces lower-than-anticipated wireless product revenue and sustained pressure on wireless prices.

BCE added 33,111 net postpaid mobile phone subscribers, down 76.8 per cent from the same period last year, which was the company’s second-best performance on the metric since 2010.

It says the drop was driven by higher customer churn — a measure of subscribers who cancelled their service — amid greater competitive activity and promotional offer intensity. BCE’s monthly churn rate for the category was 1.28 per cent, up from 1.1 per cent during its previous third quarter.

The company also saw 11.6 per cent fewer gross subscriber activations “due to more targeted promotional offers and mobile device discounting compared to last year.”

Bell’s wireless mobile phone average revenue per user was $58.26, down 3.4 per cent from $60.28 in the third quarter of the prior year.

This report by The Canadian Press was first published Nov. 7, 2024.

Companies in this story: (TSX:BCE)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Canada Goose reports Q2 revenue down from year ago, trims full-year guidance

Published

 on

 

TORONTO – Canada Goose Holdings Inc. trimmed its financial guidance as it reported its second-quarter revenue fell compared with a year ago.

The luxury clothing company says revenue for the quarter ended Sept. 29 totalled $267.8 million, down from $281.1 million in the same quarter last year.

Net income attributable to shareholders amounted to $5.4 million or six cents per diluted share, up from $3.9 million or four cents per diluted share a year earlier.

On an adjusted basis, Canada Goose says it earned five cents per diluted share in its latest quarter compared with an adjusted profit of 16 cents per diluted share a year earlier.

In its outlook, Canada Goose says it now expects total revenue for its full financial year to show a low-single-digit percentage decrease to low-single-digit percentage increase compared with earlier guidance for a low-single-digit increase.

It also says it now expects its adjusted net income per diluted share to show a mid-single-digit percentage increase compared with earlier guidance for a percentage increase in the mid-teens.

This report by The Canadian Press was first published Nov. 7, 2024.

Companies in this story: (TSX:GOOS)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending